MegaPro Biomedical Co., Ltd.
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
1. Current Progress of Product Development
2. MPB-1514
3. MPB-1523 (IOP Injection)
4. MPB-1734: A New Formulation Anti-cancer Drug
2. MPB-1514
3. MPB-1523 (IOP Injection)
4. MPB-1734: A New Formulation Anti-cancer Drug
Founded Year
2014
Unified Business No.
24765568
Status
Active
Number of Employees
0
Total Paid-in
Capital
795,239,030 (NT$)
Location of Company
Taiwan
, Hsinchu County
Exit Status
Emerging Stock Exchange(2021)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
MegaPro Biomedical Co., Ltd.'s main product is mainly the nano iron oxide.
Based on the core team that developed nano-iron oxide products in the Industrial Technology Research Institute, the company is established to focus on the development of nic
Based on the core team that developed nano-iron oxide products in the Industrial Technology Research Institute, the company is established to focus on the development of nic
